The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling

Journal of the American Society of Nephrology : JASN - United States
doi 10.1681/asn.2018020209
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Nephrology (ASN)

Related search

Targeting Resistance Against the MDM2 Inhibitor RG7388 in Glioblastoma Cells by the MEK Inhibitor Trametinib

Clinical Cancer Research
Cancer ResearchOncology
2018English

Trametinib: A MEK Inhibitor for Management of Metastatic Melanoma

OncoTargets and Therapy
OncologyPharmacology
2015English

Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts

PLoS ONE
Multidisciplinary
2012English

Correction: Micheliolide Ameliorates Renal Fibrosis by Suppressing the MTDH/BMP/Mapk Pathway

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2019English

Polydatin Ameliorates Pulmonary Fibrosis by Suppressing Inflammation and the Epithelial Mesenchymal Transition via Inhibiting the TGF-β/Smad Signaling Pathway

RSC Advances
ChemistryChemical Engineering
2019English

Crocetin Protects Against Cardiac Hypertrophy by Blocking MEK-ERK1/2 Signalling Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2010English

Pre-Treatment With Curcumin Ameliorates Cisplatin-Induced Kidney Damage by Suppressing Kidney Inflammation and Apoptosis in Rats

Drug Research
MedicineDrug Discovery
2018English

The Lysyl Oxidase Like 2/3 Enzymatic Inhibitor, PXS‐5153A, Reduces Crosslinks and Ameliorates Fibrosis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

Silencing SMOC2 Ameliorates Kidney Fibrosis by Inhibiting Fibroblast to Myofibroblast Transformation

JCI insight
Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy